Criteria
Leader criteria
Sector
Communication Services
80
Consumer Discretionary
292
Consumer Staples
106
Energy
122
Financials
467
Health Care
446
Industrials
477
Information Technology
431
Materials
223
Real Estate
119
Utilities
77
Russell 3000. FTSE Russell does not publish this list, so it is reconstructed here as the 3,000 largest US operating companies by market value. It will not match the published index name for name.
Russell 3000
| Ticker ▼ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZYME | Zymeworks Inc. | Health Care | $28.61 | up 1.4% | up 8.0% | up 49.6% | 3.9% | 84 | 8/8 | $2.1B | — | — | down 27% | 8.0× | — | down 2160% | — | Low | |
| ZVRA | Zevra Therapeutics, Inc. | Health Care | $10.28 | up 4.8% | down 6.3% | up 1.4% | 4.4% | 52 | 2/8 | $584.5M | 7.0× | — | up 86% | 3.8× | 0.40 | down 89% | — | Elevated | |
| ZTS | Zoetis Inc. | Health Care | $79.72 | down 1.0% | up 14.9% | down 43.6% | 2.3% | 15 | 1/8 | $33.9B | 12.7× | 1.24 | up 65% | 9.9× | 2.65 | up 2% | 8/9 | Low | |
| ZBIO | Zenas Biopharma, Inc. | Health Care | $28.39 | up 5.7% | up 5.3% | down 5.0% | 6.3% | 73 | 5/8 | $1.5B | — | — | down 136% | 6.4× | 0.32 | — | — | Elevated | |
| ZBH | Zimmer Biomet Holdings, Inc. | Health Care | $94.52 | down 4.1% | up 6.4% | down 4.3% | 2.5% | 49 | 5/8 | $30.1B | 42.7× | — | up 6% | 2.4× | 0.55 | up 33% | 5/9 | Low | |
| YDES | Yd Bio Ltd | Health Care | $5.94 | up 20.0% | down 19.9% | — | 15.2% | — | — | $420.5M | — | — | — | — | — | — | — | Elevated | |
| XRAY | Dentsply Sirona Inc. | Health Care | $9.53 | up 1.1% | up 7.6% | down 23.2% | 3.6% | 10 | 0/8 | $1.9B | — | — | down 36% | 1.4× | 1.50 | — | 5/9 | Elevated | |
| XNCR | Xencor Inc | Health Care | $29.82 | up 18.4% | up 19.5% | up 111.0% | 6.1% | 98 | 8/8 | $2.1B | — | — | down 14% | 3.4× | 0.12 | — | — | Low | |
| XERS | Xeris Biopharma Holdings, Inc. | Health Care | $10.71 | up 5.0% | up 12.0% | up 10.3% | 4.4% | 89 | 8/8 | $1.8B | 3213.3× | — | up 4% | 130.0× | 16.10 | — | — | Moderate | |
| XENE | Xenon Pharmaceuticals Inc. | Health Care | $37.41 | up 5.9% | up 0.6% | down 12.3% | 3.9% | 10 | 1/8 | $3.0B | — | — | down 52% | 5.1× | — | — | — | Low | |
| WVE | Wave Life Sciences, Inc. | Health Care | $3.59 | up 12.9% | down 3.0% | down 56.7% | 6.2% | 2 | 0/8 | — | — | — | down 56% | — | — | — | — | Unknown | |
| WST | West Pharmaceutical Services Inc | Health Care | $412.62 | up 5.2% | up 11.3% | up 48.6% | 2.5% | 90 | 8/8 | $29.7B | 60.2× | 38.06 | up 17% | 9.4× | 0.06 | up 57% | 8/9 | Low | |
| WRBY | Warby Parker Inc. | Health Care | $24.61 | down 5.0% | down 11.4% | up 27.7% | 5.5% | 43 | 3/8 | — | — | — | 0% | — | — | — | — | Unknown | |
| WGS | Genedx Holdings Corp. | Health Care | $69.06 | up 23.0% | down 4.5% | down 47.5% | 8.3% | 22 | 2/8 | $2.0B | — | — | down 8% | 6.6× | 0.16 | down 264% | 6/9 | Elevated | |
| WAT | Waters Corp /De/ | Health Care | $462.72 | up 2.0% | up 5.3% | up 34.9% | 3.1% | 86 | 8/8 | $27.6B | 42.9× | 87.17 | up 29% | 10.8× | 0.37 | down 156% | 6/9 | Low | |
| VTRS | Viatris Inc | Health Care | $19.04 | up 5.8% | up 7.4% | up 90.3% | 2.5% | 89 | 8/8 | $23.7B | — | — | down 21% | 1.6× | 0.85 | — | — | Elevated | |
| VSTM | Verastem, Inc. | Health Care | $9.75 | down 2.9% | up 21.1% | up 5.6% | 6.8% | 94 | 8/8 | $758.0M | — | — | down 366% | 13.3× | — | — | — | Elevated | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | Health Care | $558.88 | up 6.7% | up 6.9% | up 33.1% | 2.7% | 81 | 8/8 | $142.0B | 35.9× | — | up 23% | 7.6× | — | up 8% | 8/9 | Low | |
| VRDN | Viridian Therapeutics, Inc.\De | Health Care | $24.67 | up 10.3% | up 19.8% | up 4.3% | 3.9% | 81 | 4/8 | $2.5B | — | — | down 49% | 3.5× | — | — | — | Low | |
| VOR | Vor Biopharma Inc. | Health Care | $19.68 | up 7.8% | up 3.1% | down 21.3% | 6.3% | 64 | 6/8 | $762.0M | — | — | — | — | — | — | — | Unknown | |
| VKTX | Viking Therapeutics, Inc. | Health Care | $27.28 | up 11.8% | down 16.3% | down 28.5% | 6.5% | 22 | 1/8 | $3.1B | — | — | down 47% | 4.9× | — | — | — | Low | |
| VIR | Vir Biotechnology, Inc. | Health Care | $11.30 | up 6.9% | up 1.1% | up 90.6% | 5.6% | 91 | 8/8 | $1.6B | — | — | down 46% | 2.1× | — | — | 4/9 | Elevated | |
| VERA | Vera Therapeutics, Inc. | Health Care | $30.98 | up 10.7% | down 4.1% | up 4.4% | 5.5% | 29 | 0/8 | — | — | — | down 51% | — | 0.12 | — | — | Unknown | |
| VCYT | Veracyte, Inc. | Health Care | $50.01 | up 4.3% | up 8.6% | up 41.6% | 4.9% | 85 | 7/8 | $4.0B | 59.8× | 0.36 | up 5% | 3.0× | — | — | 7/9 | Low | |
| VCEL | Vericel Corp | Health Care | $40.26 | down 5.3% | up 0.3% | up 16.6% | 4.0% | 49 | 6/8 | $2.0B | 123.4× | 2.13 | up 5% | 5.7× | — | — | 7/9 | Low |